Autolus Therapeutics plc

AUTL

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001730463

SEC filings (opens in a new tab)

In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Autolus Therapeutics plc changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of AUTL: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Q4 2024	Change
Holders	101	110	+9
Shares	178.6M	168.4M	−10.2M (−5.7%)
Value	$648.5M	$395.4M	−$253.1M (−39.0%)

New holders (23)

Institutions that held Autolus Therapeutics plc at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to AUTL in Q4 2024
Institution	Shares	Value	% of portfolio
Candriam Luxembourg S.C.A.	3,191,401	$7.50M	0.04%
AXA S.A.	1,824,685	$4.29M	0.01%
Hennion & Walsh Asset Management, Inc.	259,980	$611.0K	0.03%
Point72 Asset Management, L.P.	247,089	$580.7K	0.00%
Alps Advisors Inc	215,190	$505.7K	0.00%
EntryPoint Capital, LLC	191,429	$449.9K	0.19%
Aubrey Capital Management Ltd	84,822	$198.9K	0.08%
Jump Financial, LLC	72,396	$170.1K	0.00%
HighPoint Advisor Group LLC	78,620	$150.2K	0.01%
Acadian Asset Management LLC	56,273	$131.0K	0.00%
Omers Administration Corp	36,300	$85.3K	0.00%
Avanza Fonder AB	31,770	$74.7K	0.00%
Arkadios Wealth Advisors	20,000	$47.0K	0.00%
Dumont & Blake Investment Advisors LLC	15,000	$35.3K	0.01%
Jane Street Group, LLC	11,271	$26.5K	0.00%
R Squared Ltd	4,680	$11.0K	0.01%
GF Fund Management Co. Ltd.	4,193	$9.85K	0.00%
Caitong International Asset Management Co., Ltd	1,172	$2.75K	0.00%
Royal Bank of Canada	682	$2.00K	0.00%
Caldwell Sutter Capital, Inc.	500	$1.18K	0.00%
Truvestments Capital LLC	500	$1.18K	0.00%
Skopos Labs, Inc.	377	$886	0.00%
SBI Securities Co., Ltd.	50	$118	0.00%

Sold out (14)

Institutions that held Autolus Therapeutics plc at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of AUTL in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Deerfield Management Company, L.P. (Series C)	3,639,000	$13.2M
Adage Capital Partners GP, L.L.C.	2,950,000	$10.7M
StemPoint Capital LP	2,616,602	$9.50M
Gsa Capital Partners LLP	298,086	$1.08M
Octagon Capital Advisors LP	176,000	$638.9K
Voloridge Investment Management, LLC	121,035	$439.4K
TD Asset Management Inc	98,406	$357.2K
D. E. Shaw & Co., Inc.	91,687	$332.8K
Altfest L J & Co Inc	21,820	$79.0K
Capstone Investment Advisors, LLC	13,951	$50.6K
ProShare Advisors LLC	11,796	$42.8K
Franklin Resources Inc	10,000	$41.8K
Golden State Equity Partners	3,900	$14.2K
NBC Securities, Inc.	800	$2.00K